Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 104,838 shares at $11.20 ($1.2M) on 2025-01-17, disclosed to the SEC on 2025-01-22.
Scheduled sale ($1.2M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.20 | 52,419 | $587K | 50.0% |
| 2 | $11.20 | 52,419 | $587K | 50.0% |
| Total | $11.20 avg | 104,838 | $1.2M | 100% |
| Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |
| PLRX | SELL | 2023-04-03 | $1.9M | — | Filing → |